Podiatrists in Rio Rancho, NM Accepting Medicare
7 Podiatrists found. Showing 1 - 7
 Dr. Silas Klaver, D.P.M. Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 2400 Unser Blvd Se Ste 8100, Rio Rancho, NM 87124 Phone: 505-253-6100 |
 Michael R Pincus Dpm Llc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 2207 Golf Course Rd Se Ste A, Rio Rancho, NM 87124 Phone: 505-896-1500 Fax: 505-896-1113 |
George C Ochs, DPM Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 2400 Unser Blvd Se Ste 8100, Rio Rancho, NM 87124 Phone: 505-253-6100 Fax: 505-253-6101 |
Dr. Michael Robert Pincus, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 2207 Golf Course Rd Se Ste A, Ste A, Rio Rancho, NM 87124 Phone: 505-896-1500 Fax: 505-896-1113 |
 Uche Nkiru Motanya, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 2400 Unser Blvd Se, Rio Rancho, NM 87124 Phone: 505-226-2040 |
Cole Barton, DPM Podiatrist Medicare: Medicare Enrolled Practice Location: 2207 Golf Course Rd Se Ste A, Rio Rancho, NM 87124 Phone: 505-896-1500 Fax: 505-896-1113 |
Dr. Timothy Chan I, DPM Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 2207 Golf Course Rd Se Ste A, Rio Rancho, NM 87124 Phone: 575-521-0055 |
News Archive
Berkeley Lab researchers develop new mouse model for most common form of breast cancer
The first clinically-relevant mouse model of human breast cancer to successfully express functional estrogen receptor positive (ER+) adenocarcinomas has been developed by researchers at Lawrence Berkeley National Laboratory.
Shape of blood flow in heart's upper left chamber may help predict stroke risk
Using specialized CT scans of a healthy heart and one with heart disease, a team of Johns Hopkins cardiologists and biomedical engineers say they've created computer models of the "shape" of blood flow through the heart's upper left chamber that someday may help predict stroke risk.
Alexion first quarter non-GAAP net income increases to $56.3 million
Alexion Pharmaceuticals, Inc. today announced financial results for the three months ended March 31, 2011. Alexion Pharmaceuticals, Inc. reported net product sales of Soliris® (eculizumab) of $166.1 million, reflecting steady additions of new patients, compared to $117.6 million for the same period in 2010.
Guts of surfers more likely to be colonized by antibiotic-resistant bacteria, study reveals
Regular surfers and bodyboarders are three times more likely to have antibiotic resistant E. coli in their guts than non-surfers, new research has revealed.
› Verified 2 days ago
Speech-Language Pathologists
Physical Therapists
Occupational Therapists
Chiropractors
Optometrists
Podiatrists
Audiologists